Article Information
History
- October 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Ai-ris Y. Collier, MD1,2,3,
- Catherine M. Brown, DVM4,
- Katherine Mcmahan, MS1,
- Jingyou Yu, PhD1,
- Jinyan Liu, PhD1,
- Catherine Jacob-Dolan, BS1,2,
- Abishek Chandrashekar, MS1,
- Dylan Tierney, MD, MPH4,
- Jessica L. Ansel, NP1,
- Marjorie Rowe, BS1,
- Daniel Sellers, BS1,
- Kunza Ahmad, MS1,
- Ricardo Aguayo, BS1,3,
- Tochi Anioke, BS1,
- Sarah Gardner, BS1,
- Mazuba Siamatu, BS1,
- Lorraine Bermudez Rivera, BS1,
- Michele R. Hacker, ScD2,3,
- Lawrence C. Madoff, MD4 and
- Dan H. Barouch, MD, PhD1,2,5,*
- 1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
- 2Harvard Medical School, Boston, MA, USA
- 3Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA
- 4Massachusetts Department of Public Health, Boston, MA, USA
- 5Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA
- ↵*Corresponding Author:
Dan H. Barouch, MD, PhD, Center for Virology and Vaccine Research, 330 Brookline Avenue, E/CLS-1043, Boston, MA 02115; Telephone: 617-735-4485; Fax: 617-735-4566; Email: dbarouch{at}bidmc.harvard.edu
Posted October 20, 2021.
Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
